0001437749-13-000783.txt : 20130128
0001437749-13-000783.hdr.sgml : 20130128
20130128190306
ACCESSION NUMBER: 0001437749-13-000783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130124
FILED AS OF DATE: 20130128
DATE AS OF CHANGE: 20130128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hart Danny J Jr.
CENTRAL INDEX KEY: 0001518546
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 13553195
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BOULEVARD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
4
1
rdgdoc.xml
PRIMARY DOCUMENT
X0306
4
2013-01-24
0000882104
PDL BIOPHARMA, INC.
PDLI
0001518546
Hart Danny J Jr.
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
1
Dep. Gen Counsel/Asst Secry
Common Stock
2013-01-24
4
A
0
4494
6.72
A
15104
D
The shares will vest on December 12, 2014, provided I am continuously employed by the Company through such date. In the event I am terminated by PDLI without cause or resign for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, I have the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDLI. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest.
/s/ Danny J. Hart, Jr.
2013-01-28